Formulations:
- Parenteral > General injections > IV: 6 mg per mL
Indications:
- Other specified malignant neoplasms of the ovary
- Other specified malignant neoplasms of bronchus or lung
- Malignant neoplasms of nasopharynx
- Kaposi sarcoma of unspecified primary site
- Other specified malignant neoplasms of breast
- Other specified carcinomas of ovary
- Malignant neoplasms of breast
- Malignant neoplasms of cervix uteri
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > IV: 6 mg per mL
Indications:
- Other specified malignant neoplasms of the ovary
- Other specified malignant neoplasms of bronchus or lung
- Malignant neoplasms of nasopharynx
- Kaposi sarcoma of unspecified primary site
- Other specified malignant neoplasms of breast
- Other specified carcinomas of ovary
- Malignant neoplasms of breast
- Malignant neoplasms of cervix uteri
Source: EML workbook import